Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 196.51M P/E - EPS this Y - Ern Qtrly Grth -
Income 22.27M Forward P/E - EPS next Y - 50D Avg Chg -10.00%
Sales 80.47M PEG - EPS past 5Y - 200D Avg Chg -10.00%
Dividend N/A Price/Book 1.93 EPS next 5Y - 52W High Chg -27.00%
Recommedations - Quick Ratio 3.64 Shares Outstanding 49.91M 52W Low Chg 12.00%
Insider Own - ROA 6.51% Shares Float 41.87M Beta 1.09
Inst Own 0.15% ROE 25.91% Shares Shorted/Prior 58.18K/60K Price 3.67
Gross Margin 100.00% Profit Margin 27.68% Avg. Volume 106,853 Target Price -
Oper. Margin 51.00% Earnings Date Sep 19 Volume 17,947 Change 2.23%
About GENFIT S.A.

Genfit S.A., a late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company develops Elafibranor, which is in Phase III clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; VS-01 for the treatment of Urea Cycle Disorder (UCD) and Organic Acidemia Disorder (OAD); GNS561, which is in Phase 1b/2a trial to treat patients with cholangiocarcinoma (CCA); VS-01-ACLF and Nitazoxanide (NTZ), which is in Phase 1 trial to treat acute-on-chronic liver failure, as well as VS-02-HE, which is in preclinical trial for the treatment of Reduction of Hyperammonemia and the Stabilization of Blood Ammonia; CML-022; SRT-015, an ASK1 inhibitor targets the inhibition of cellular apoptosis, inflammation, and fibrosis. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. The company was incorporated in 1999 and is headquartered in Loos, France.

GENFIT S.A. News
11/13/24 GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024
11/07/24 GENFIT Reports Third Quarter 2024 Financial Information
10/17/24 High Growth Tech Stocks in France for October 2024
10/15/24 High Growth Tech Stocks in France to Watch This October 2024
10/14/24 Believe Leads These 3 High Growth Tech Stocks In France
10/11/24 High Growth Tech Stocks In France October 2024
10/10/24 High Growth Tech Stocks in France to Watch October 2024
10/09/24 Exclusive Networks And 2 High Growth Tech Stocks In France
09/24/24 Esker And Two High Growth Tech Stocks In France
09/23/24 GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval
09/19/24 GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update
07/26/24 GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis
07/09/24 GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
06/17/24 GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH
06/10/24 GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis
05/29/24 GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
05/22/24 GENFIT: May 22, 2024 Combined Shareholders Meeting Results
05/14/24 GENFIT Reports First Quarter 2024 Financial Information
04/25/24 GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)
04/15/24 GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory Documents
GNFT Chatroom

User Image CharleighRangel Posted - 1 day ago

$ACIU $ADCT $GNFT LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?

User Image Gregory0Villarreal Posted - 6 days ago

$ADCT $GNFT MYNZ Wow, this is insane news! Don't miss out. The train is leaving the station. Add it to your watchlist to see what happens next. 😏

User Image yourwellwisher Posted - 2 weeks ago

$GNFT making the move after hours. Soon double digits as planned

User Image FastTrack2Wealth Posted - 2 weeks ago

🚨 MYNZ HUGE PR drop incoming before the Nov 13 meeting 🔥 Someone is pushing these dates of upcoming NEWS 3 biggest stock alert channels announced, might consider to add now, who knows. $GNFT $AVIR $VNDA $ELDN

User Image justiceforb_85 Posted - 10/24/24

$GNFT awaiting read-outs for cholangiocarcinoma and acute-on-chronic liver failure treatments.

User Image cacaelma Posted - 10/23/24

$GNFT from Ipsen's YTD 2024 sales update related to the launch of Iqirvo licensed form $GNFT

User Image yourwellwisher Posted - 1 month ago

$GNFT coming together. Wait for the news as it pops into double digits.

User Image yourwellwisher Posted - 1 month ago

Watch out for $GNFT in coming weeks

User Image justiceforb_85 Posted - 1 month ago

$GNFT $XBI very under the radar. Data for GNS561 in cholangiocarcinoma out later this year.

User Image BLD33 Posted - 1 month ago

$GNFT starting to go higher

User Image Doozio Posted - 1 month ago

$GNFT 🧠⏰♾️

User Image anachartanalyst Posted - 1 month ago

$GNFT https://anachart.com/wp-content/uploads/ana_temp/1728644474_soc-img.jpg

User Image Stocks4thought Posted - 09/30/24

$GNFT Rockin it$

User Image Doozio Posted - 09/29/24

$GNFT a gap n go if da FUTUre of 🧠⏰ is NOW during 🧠⏰♾️?

User Image PenkeTrading Posted - 09/25/24

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Genfit. Is that bullish or bearish? $GNFT #Genfit #RsiOverbought #NASDAQ

User Image Stocks4thought Posted - 09/25/24

$GNFT The Jeans fit her- new high coming- biliary.

User Image Michael0197 Posted - 09/24/24

$GNFT Congratulations to all GNFT shareholders..... I hope we can look forward to similar or greater in the near and intermediate future..... 👍

User Image RallyRaider Posted - 09/24/24

$GNFT seggsy weekly chart lots of higher lows now coming up again

User Image Doozio Posted - 1 month ago

$GNFT a 🧠👀 is NOW 🧠⏰

User Image justiceforb_85 Posted - 2 months ago

$GNFT $XBI looking forward to data on pipeline drug for acute on chronic liver failure.

User Image frenchflair Posted - 2 months ago

$GNFT Hi lovely RICAINS vous n'avez pas l'air d'être au courant de cette news énorme tombée dans l'après midi bisous bisous de france french kiss https://www.boursorama.com/bourse/actualites/ipsen-iqirvo-approuve-dans-la-cbp-dans-l-ue-ff6e688a7031fd306edebbbd479c452a?symbol=1rPIPN

User Image Stocks4thought Posted - 2 months ago

$GNFT TAM for Bilary?

User Image thetechtrader Posted - 2 months ago

$GNFT popped, flagged. If it pops w/vol, extension targets are 5.60-65 & 6-6.15. Support 5 & 4.75. #stockstowatch #daytrading #swingtrading #daytrader #stockmarket #technicalanalysis #harryboxer #priceaction #smartmoney #chartanalysis #swingtrading #swingtrade #daytrade #daytrading #tradingtips #investing #thetechtrader #marketnews #marketanalysis

User Image OpenOutcrier Posted - 2 months ago

$GNFT (+15.3% pre) GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update - GN https://ooc.bz/l/42922

User Image topstockalerts Posted - 2 months ago

Pre Market Top Gainers PT2 $GDHG $TNON $GNFT $AENT $KLTO

User Image gnomed Posted - 07/26/24

$GNFT uhhh did someone accidentally click sell instead of buy?

User Image codekitty Posted - 07/26/24

For example here's a company $GNFT that got approval on June 11th. should we expect the same here?

User Image DonCorleone77 Posted - 07/26/24

$GNFT Genfit announces positive CHMP opinion for Ipsen's Iqirvo GENFIT (GNFT) announced the positive opinion issued by the Committee for Medicinal Products for Human Use of the European Medicines Agency's for Ipsen's (IPSEY) Iqirvo for the treatment of Primary Biliary Cholangitis in combination with ursodeoxycholic acid in adults with an inadequate response to UDCA or as a monotherapy in patients unable to tolerate UDCA. Elafibranor, a molecule marketed and commercialized in the United States by Ipsen under the trademark Iqirvo since June 2024, was developed by GENFIT, from initial discovery to the conclusion of a 52-week Phase 3 clinical study. Ipsen licensed the exclusive worldwide rights to elafibranor from GENFIT in 2021. The European Commission will now consider the CHMP recommendations, and a final decision on marketing authorization for Iqirvo is anticipated in the second half of 2024.

User Image justiceforb_85 Posted - 07/22/24

$GNFT when do we anticipate updated data for VS-01?

User Image Milanfinest Posted - 4 months ago

$GNFT so can someone help? i ll pay back

Analyst Ratings
HC Wainwright & Co. Buy Sep 20, 24
HC Wainwright & Co. Buy Jul 29, 24
HC Wainwright & Co. Buy Jun 11, 24
HC Wainwright & Co. Buy Jun 6, 24
HC Wainwright & Co. Buy May 15, 24
HC Wainwright & Co. Buy Apr 5, 24
HC Wainwright & Co. Buy Dec 8, 23
HC Wainwright & Co. Buy Sep 21, 23
HC Wainwright & Co. Buy Jul 3, 23